Literature DB >> 20101320

Patch testing in chronic urticaria.

Kiran V Godse.   

Abstract

Entities:  

Year:  2009        PMID: 20101320      PMCID: PMC2807164          DOI: 10.4103/0019-5154.53177

Source DB:  PubMed          Journal:  Indian J Dermatol        ISSN: 0019-5154            Impact factor:   1.494


× No keyword cloud information.
Sir, This is with reference to the article entitled “Use of patch testing for identifying allergen causing chronic urticaria” which appeared in the March–April issue of IJDVL.[1] The article illustrates the use of patch testing in the diagnosis of chronic urticaria. Author found 11 patients out of 57 with positive patch test. On avoidance of allergens, nine out of 11 patients showed complete disappearance of urticaria. All 11 patients experienced quick relapse after returning to normal lifestyle and diet. Author fails to mention the duration of chronic urticaria and severity of urticaria. The urticaria activity score consist of the sum of the wheal number score and the itch severity score.[2] The wheal numbers are graded from 0 to 3 as follows: 0 – less than 10 small wheals (diameter, <3cm); 1 – 10 to 50 small wheals or less than 10 large wheals (diameter, > 3 cm); 2 - greater than 50 small wheals or 10–50 large wheals; and 3 - almost the whole body is covered. The severity of the itching is graded from 0 to 3 (0, none; 1, mild; 2, moderate; and 3, severe). This scoring system is often used in the assessment of urticaria activity. Author mentions urticaria reduced to half in the progress report, which is difficult to understand. A control group without chronic urticaria was not included in the study. None of the patients underwent autologous serum skin test, which can be done with the help of pathology laboratory. Mamatha, et al. and Bajaj, et al. mentions about positive autologous serum skin test in 34 and 49.5% of patients, respectively.[34] Greaves and Kaplan demonstrated the presence of circulating histamine–releasing factors in a proportion of patients with CU. Such factors were subsequently characterized as functionally active IgG autoantibodies specific for the high-affinity IgE receptor, FcEpsilon RI, or for IgE, able to induce degranulation of mast cells and basophils.[56] Autologous serum skin test (ASST) is a simple test to detect autoreactivity in vivo in patients with chronic urticaria. ASST is the only practicable test available to clinicians to detect autoimmune urticaria in India.[7] The real challenge is to find out the cause of remaining 50% patients who are ASST negative. Before the advent of ASST, chronic urticaria was considered as a mysterious disease possibly caused by anxiety and intolerance to foods, food dyes, or food additives. Many patients were advised restrictive diets for the treatment of urticaria. Similar views are expressed by Asero et al., in the Blue journal.[8] Observations of Sharma are of interest but need to be confirmed by other controlled studies before routine patch testing and avoidance measures are recommended in the diagnosis and treatment of chronic urticaria.
  8 in total

Review 1.  Chronic urticaria.

Authors:  M Greaves
Journal:  J Allergy Clin Immunol       Date:  2000-04       Impact factor: 10.793

Review 2.  Clinical practice. Chronic urticaria and angioedema.

Authors:  Allen P Kaplan
Journal:  N Engl J Med       Date:  2002-01-17       Impact factor: 91.245

3.  Chronic urticaria: one step forward and two steps back.

Authors:  Riccardo Asero; Massimo Cugno; Alberto Tedeschi
Journal:  J Am Acad Dermatol       Date:  2007-08       Impact factor: 11.527

4.  Autologous serum therapy in chronic urticaria: old wine in a new bottle.

Authors:  A K Bajaj; Abir Saraswat; Amitabh Upadhyay; Rajetha Damisetty; Sandipan Dhar
Journal:  Indian J Dermatol Venereol Leprol       Date:  2008 Mar-Apr       Impact factor: 2.545

5.  Chronic idiopathic urticaria: comparison of clinical features with positive autologous serum skin test.

Authors:  Mamatha George; C Balachandran; Smitha Prabhu
Journal:  Indian J Dermatol Venereol Leprol       Date:  2008 Mar-Apr       Impact factor: 2.545

6.  Use of patch testing for identifying allergen causing chronic urticaria.

Authors:  Ashimav Deb Sharma
Journal:  Indian J Dermatol Venereol Leprol       Date:  2008 Mar-Apr       Impact factor: 2.545

7.  The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind, placebo-controlled, crossover clinical study.

Authors:  Zülal Erbagci
Journal:  J Allergy Clin Immunol       Date:  2002-09       Impact factor: 10.793

8.  Autologous serum skin test in chronic idiopathic urticaria.

Authors:  Kiran V Godse
Journal:  Indian J Dermatol Venereol Leprol       Date:  2004 Sep-Oct       Impact factor: 2.545

  8 in total
  1 in total

1.  How Effective is Autologous Serum Therapy in Chronic Autoimmune Urticaria.

Authors:  Imran Majid; Shazia Shah; Altaf Hassan; Saima Aleem; Khalid Aziz
Journal:  Indian J Dermatol       Date:  2015 Jan-Feb       Impact factor: 1.494

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.